Nextleaf Solutions Ltd. (OILS) (
CSE.OILS) – “the world's most innovative cannabis extractor” that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids – has announced that its wholly-owned subsidiary, Nextleaf Labs Ltd., has received acceptance of its application for a Controlled Substances Dealer's Licence, now formally under review by Health Canada.
Paul Pedersen, co-founder and CEO, of Nextleaf commented:
"With our Company's unprecedented track record securing issued U.S. patents for the extraction of cannabinoids, Nextleaf is well positioned to mirror that success with psilocybin extraction. We anticipate that a Dealer's Licence will be a major catalyst with respect to Nextleaf's Specialty Molecules Division, which is focused on the development and commercialization of novel psychoactive compounds for their potential therapeutic benefits."
Full story
here.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.